Wellbiotec Co., Ltd. (010600.KS) KSC

Currency In KRW

AD

Valuation

Market Cap43.16B
Enterprise Value37.61B
P/E Ratio-0.04
PEG Ratio0
Price/Sales Ratio0.01
Price/Book Ratio0.04
Enterprise/Revenue-0.05
Enterprise/EBITDA0.28

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.25
Operating Margin-0.03
AD

Management Effectiveness

Return On Assets-0.66
Return On Equity-0.73

Income Statement

Revenue83.3B
Revenue/Share1,051.82
Gross Profit9.7B
EBITDA-15.99B
Net Income-21.22B
Diluted EPS-267.94

Balance Sheet

Total Cash6.5B
Total Cash/Share105.77
Total Debt1.41B
Total Debt/Equity0.09
Current Ratio2.23
Book Value Per Share254.86

Price History

52-Week Change-97.98
52-Week High545
52-Week Low11
Moving Average 50 Days471.3
Moving Average 200 Days526.58

Statistics

Average Volume4.02M
Shares Outstanding90.92M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateOctober 28, 2011
AD